文献速递眼底病与葡萄膜炎

广泛性黄斑萎缩伴假性玻璃膜疣样外观(EMAP)的临床特征、诊断标准及与相关遗传性视网膜疾病和年龄相关性黄斑变性的比较见解

Extensive macular atrophy with pseudodrusen-like appearance (EMAP) clinical characteristics, diagnostic criteria, and insights from allied inherited retinal diseases and age-related macular degeneration.
PubMed 文献 · Prog Retin Eye Res · 2024-11-25

本文综述了2009年首次在法国描述的广泛性黄斑萎缩伴假性玻璃膜疣样外观(EMAP),该病主要影响中年人,呈对称性和快速进展性黄斑萎缩。文章总结了EMAP的临床三联征、分期依赖的新标志(如Bruch膜与视网膜色素上皮弥漫分离及黄斑颞侧区域保留),并基于全球最大EMAP队列的未发表数据提出了一套结合临床、影像和功能检查的诊断标准,同时通过与年龄相关性黄斑变性(AMD)和类似表型的单基因视网膜疾病比较探讨其发病机制。

要点

  • EMAP典型临床三联征为垂直方向多小叶边界的黄斑萎缩、后极部和中周部假性玻璃膜疣样沉积及周边铺路石样变性。
  • EMAP呈高度分期依赖,新认识包括Bruch膜与视网膜色素上皮弥漫分离及黄斑颞侧区域保留。
  • 视网膜电生理有助于区分EMAP与年龄相关性黄斑变性(AMD)。

核心结论

  • EMAP现被认为是一种以弥漫性脉络膜视网膜萎缩和光感受器功能障碍为特征的严重致盲性疾病。
  • 本文提出了一套结合临床、影像和功能检查的诊断标准以促进该临床实体的识别。
  • 本文通过与AMD和表现相似表型的单基因视网膜疾病比较来阐明EMAP的发病机制。

研究设计与样本

  • 本文为综述,基于全球最大EMAP队列的未发表数据,对EMAP的临床特征、诊断标准和发病机制进行综合描述。

主要发现

  • EMAP于2009年首次在法国描述,主要影响中年人,呈对称性和快速进展性黄斑萎缩。
  • EMAP典型临床三联征包括垂直方向多小叶边界的黄斑萎缩、后极部和中周部假性玻璃膜疣样沉积及周边铺路石样变性。
  • EMAP呈高度分期依赖,新发现的疾病标志包括Bruch膜与视网膜色素上皮弥漫分离以及黄斑颞侧区域一致性保留。
  • 视网膜电生理在区分EMAP与年龄相关性黄斑变性(AMD)方面特别有用。

关键数值与推荐

  • 本文提出的诊断标准纳入临床、影像和功能检查,以促进EMAP的识别。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Extensive macular atrophy with pseudodrusen-like appearance (EMAP) was first described in France in 2009 as a symmetric and rapidly progressive form of macular atrophy primarily affecting middle-aged individuals. Despite the recent identification of a significant number of cases in Italy and worldwide, EMAP remains an underrecognized condition. The clinical triad typical of EMAP consists of vertically oriented macular atrophy with multilobular borders, pseudodrusen-like deposits across the posterior pole and mid-periphery, and peripheral pavingstone degeneration. Nonetheless, recent research has portrayed EMAP as a highly stage-dependent condition, allowing the identification of novel disease hallmarks, including a diffuse separation between the Bruch's membrane and the retinal pigment epithelium, along with consistent sparing of a region temporal to the macula. Additionally, retinal electrophysiology is particularly useful in distinguishing EMAP from age-related macular degeneration (AMD). Supported by unpublished data from the largest EMAP cohorts worldwide, this review aims to provide a comprehensive and updated description of EMAP, now recognized as a severely blinding disease characterized by diffuse chorioretinal atrophy and photoreceptor dysfunction. Furthermore, we propose a set of diagnostic criteria that incorporate clinical, imaging, and functional tests, to facilitate the recognition of this clinical entity. Lastly, we aim to shed light on its pathogenesis by comparing it with AMD and monogenic retinal disorders exhibiting similar phenotypes.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Antropoli A, Bianco L, Romano F, et al. Extensive macular atrophy with pseudodrusen-like appearance (EMAP) clinical characteristics, diagnostic criteria, and insights from allied inherited retinal diseases and age-related macular degeneration. Prog Retin Eye Res. 2024. PMID: 39603590. doi:10.1016/j.preteyeres.2024.101320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。